3 glp 1 drugs Comparing Ozempic, Wegovy and Other GLP-1 GLP-1 drugs like Ozempic &

The promising obesity outcomes enabled by drugs such as Wegovy have prompted other drug manufacturers to pursue their own development efforts to help claim their share of this unprecedented market opportunity

[DOI] [PMC free article] [PubMed] [Google Scholar] 2.Wang J.-Y., et al

In a study by Ye et al., the protective effects of Liraglutide on glomerular podocytes in obese mice by inhibiting the inflammatory factor Tumor necrosis factor (TNF)--mediated NF-B and MAPK pathway was examined [77]

This structural parallelism makes them excellent companion reference compounds in preclinical research because many physicochemical properties such as solubility, albumin binding, and subcutaneous depot behavior are comparable, isolating receptor pharmacology as the primary experimental variable

Back Rehfeld, JF (March 2021) "Cholecystokinin and the hormone concept', Endocrine Connections , 10/3

2024, doi: 10.1038/s41591-024-02996-7